PMC6560331_01
WBC count trend (the therapy with ceftolozane/tazobactam started on day 19').
CRIOG2019-8463693.003.jpg
PMC6560331_01_CRIOG2019-8463693.003.jpg
fig3
The patient presented a marked Leucopenia: WBC: 0,740 cells/mm3 treated with filgrastim a granulocyte colony-stimulating factor (G-CSF) 10 mcg/kg once daily until the cells went back to 2,000/mm3 (the WBC count trend is described in Figure 3).
Temperature trend (the therapy with ceftolozane/tazobactam started on day 19').
CRIOG2019-8463693.004.jpg
PMC6560331_01_CRIOG2019-8463693.004.jpg
fig4
Figure 4), hypotension, and respiratory failure. For this reason she was transferred to intensive care unit (ICU).